The Veterinary CRO and CDMO Market was valued at USD 7.37 Bn in 2025 and is expected to reach USD 16.28 Bn by 2034, at a CAGR of 9.2% during the forecast period.
The global Veterinary CRO and CDMO Market is witnessing remarkable growth as pharmaceutical companies increasingly rely on outsourcing partners to accelerate veterinary drug development, improve manufacturing efficiency, and navigate complex regulatory requirements.
Understanding the Veterinary CRO and CDMO Market
Veterinary CROs provide research services such as preclinical studies, clinical trials, regulatory support, and data management for animal health products. CDMOs complement these services by offering formulation development, process optimization, manufacturing, packaging, and commercialization support for veterinary pharmaceuticals.
Together, these organizations help pharmaceutical companies reduce development costs, shorten product launch timelines, and maintain compliance with increasingly stringent global regulations. As animal health companies focus on innovation rather than infrastructure, outsourcing has become a strategic necessity rather than simply a cost-saving option.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://www.stellarmr.com/report/req_sample/veterinary-cro-and-cdmo-market/2811
Why the Market Is Growing Rapidly
Several long-term industry trends are contributing to the expansion of the Veterinary CRO and CDMO Market.
Growing Companion Animal Population
Pet ownership continues to increase across developed and emerging economies. Companion animals are increasingly regarded as family members, leading owners to spend more on preventive healthcare, specialty medicines, vaccines, diagnostics, and advanced treatments.
This trend is encouraging pharmaceutical companies to develop innovative veterinary products while partnering with CROs and CDMOs to accelerate commercialization.
Rising Livestock Production
The growing global demand for meat, dairy, and poultry products has intensified livestock production. Maintaining animal health has become essential for food safety, productivity, and disease prevention.
Veterinary outsourcing organizations support livestock medicine development by conducting research, manufacturing vaccines, and ensuring regulatory compliance, making them critical partners in modern agriculture.
Expansion of Veterinary Biologics
Biologics, including vaccines, monoclonal antibodies, and cell-based therapies, represent one of the fastest-growing areas of veterinary medicine. These products require specialized research capabilities and sophisticated manufacturing facilities.
Many pharmaceutical companies lack these resources internally, making CDMOs valuable partners for biologics development and commercial-scale production.
Market Segmentation
The Veterinary CRO and CDMO Market is segmented by animal type, service, application, and region.
By Animal Type
Companion Animals
Livestock Animals
Companion animals account for a significant share of market demand due to increasing healthcare expenditure and growing awareness of preventive veterinary care.
By Service
The market includes several specialized services:
Discovery
Development
Manufacturing
Packaging and Labeling
Market Approval and Post-Marketing
Manufacturing and development services continue to generate substantial revenue as pharmaceutical companies seek integrated outsourcing partners capable of supporting products from early research through commercial production.
By Application
The market serves two primary applications:
Medicines
Medical Devices
Medicines currently dominate the market because of continuous investments in pharmaceuticals, vaccines, and biologics, while medical devices are expected to experience faster growth due to increasing adoption of advanced veterinary diagnostics and monitoring technologies.
Technological Innovations Driving Market Growth
Technology is reshaping veterinary research and manufacturing across the entire value chain.
Artificial intelligence is improving clinical trial design, predictive toxicology, biomarker identification, and drug discovery. Machine learning algorithms help researchers analyze complex biological data, reducing development timelines while improving research accuracy.
Digital laboratory management systems, cloud-based documentation, automation, and advanced manufacturing analytics are also enabling CROs and CDMOs to deliver higher operational efficiency and better regulatory compliance.
In manufacturing, continuous processing technologies and automated quality control systems are improving production consistency while reducing operational costs. These innovations strengthen the competitive position of outsourcing providers globally.
Regional Market Outlook
North America
North America remains the largest Veterinary CRO and CDMO Market due to its well-established pharmaceutical industry, advanced veterinary healthcare infrastructure, significant R&D investment, and strong regulatory framework.
The United States leads the region with extensive clinical research activities and a large number of contract service providers supporting animal health companies.
Europe
Europe continues to experience steady market growth, supported by increasing biologics research, expanding veterinary pharmaceutical innovation, and strict quality standards for animal healthcare products.
Growing collaboration between pharmaceutical manufacturers and specialized outsourcing companies is further strengthening regional demand.
Asia-Pacific
Asia-Pacific is expected to record the fastest growth during the forecast period.
Countries including China, India, Japan, and South Korea are investing heavily in veterinary infrastructure, livestock health management, biotechnology research, and pharmaceutical manufacturing. Rising pet ownership and expanding commercial farming activities are creating significant opportunities for CROs and CDMOs throughout the region.
Challenges Facing the Industry
Despite its strong growth prospects, the Veterinary CRO and CDMO Market faces several challenges.
Developing veterinary medicines requires substantial financial investment in research, manufacturing facilities, regulatory compliance, and quality assurance systems. Smaller companies may struggle to meet these requirements while remaining competitive.
Additionally, regulatory requirements continue to evolve across different countries, increasing the complexity of product approvals and extending development timelines.
Another challenge is the shortage of experienced veterinary scientists, biologics specialists, and regulatory professionals needed to support increasingly sophisticated outsourcing projects.
Competitive Landscape
Competition within the Veterinary CRO and CDMO Market is centered on integrated service capabilities, manufacturing expertise, regulatory knowledge, and global operational reach.
Leading companies are expanding laboratory infrastructure, investing in biologics manufacturing, strengthening digital capabilities, and pursuing strategic collaborations to broaden their service portfolios.
Major industry participants include:
Zoetis Inc.
Charles River Laboratories
WuXi AppTec
Eurofins Scientific SE
Vetio Animal Health
Inotiv Inc.
KLIFOVET GmbH
Ourofino Saúde Animal
These organizations continue investing in research capacity, advanced manufacturing technologies, and global partnerships to address the growing demand for outsourced veterinary development services.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://www.stellarmr.com/report/req_sample/veterinary-cro-and-cdmo-market/2811
Future Outlook
The future of the Veterinary CRO and CDMO Market appears highly promising as pharmaceutical companies continue shifting toward outsourced research and manufacturing models. Increasing investments in companion animal healthcare, livestock disease prevention, biologics, precision medicine, and advanced veterinary technologies are expected to sustain strong market growth through 2032.
At the same time, artificial intelligence, automation, digital quality management systems, and environmentally sustainable manufacturing practices will redefine how veterinary products are developed and commercialized. Organizations capable of delivering end-to-end solutions—from discovery and clinical research to commercial manufacturing and regulatory support—will be well positioned to capitalize on the industry’s expanding opportunities.
As the global focus on animal health, food security, and innovative veterinary therapeutics continues to strengthen, CROs and CDMOs will remain central to accelerating product development, reducing costs, and bringing next-generation veterinary solutions to market faster than ever before.
Media Contact
Stellar Market Research
Website: Stellar Market Research – Global Research Reports & Consulting
Email: sales@stellarmr.com
